|
Dobrovolskaya O.V., Feklistov A.Yu., Kozyreva M.V., Demin N.V., Toroptsova N.V.
Osteoporosis and sarcopenia: association with nutritional status and physical performance in women with rheumatoid arthritis
|
№2 / 2024
|
|
N.L. Ryabkova, I.M. Marusenko, N.D. Silvestrova, Ya.A. Avdeeva, V.A. Ryabkov
Comorbid infections in patients with rheumatic diseases in the Republic of Karelia: a retrospective analysis (according to the data from Republican Hospital n.a. V.A. Baranov, Petrozavodsk)
|
№9/10 / 2023
|
|
D.V. Bestaev (1), A.A. Konushkaliev (1, 2)
On the question of systemic manifestations of early-onset rheumatoid arthritis
|
№13 / 2021
|
|
A.A. Kondrashov, N.A. Shostak
Bone mineral density and androgenic status in men with rheumatoid arthritis
|
№12 / 2021
|
|
S.S. Dotsenko, L.N. Shilova
CLINICAL AND LABORATORY PREDICTORS OF EFFECTIVENESS OF BACKGROUND THERAPY IN RHEUMATOID ARTHRITIS
|
№19 / 2017
|
|
E.A. Leushina, O.A. Koshkina, E.G. Saltykova
DIFFICULTIES IN DIAGNOSTICS AND PHARMACOTHERAPY OF RHEUMATOID ARTHRITIS: CLINICAL CASE
|
№s3-17 / 2017
|
|
S.A. Smakotina (1), A.R. Zelendinova (1), I.N. Bondareva (2), N.V. Fomina (1), S.A. Berns (3), A.A. Golikova (3)
ATORVASTATIN IN THE PREVENTION OF CARDIOVASCULAR DISEASES IN FEMALE PATIENTS WITH RHEUMATOID ARTHRITIS
|
№9 / 2017
|
|
P.S. Kovalenko, I.S. Dydykina, A.V. Smirnov, S.I. Glukhova, L.I. Alekseeva, E.L. Nasonov
THE EXPERIENCE OF THE USE OF DENOSUMAB IN THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS WITH OSTEOPOROSIS
|
№7 / 2017
|
|
I.M. Marusenko
EXPERIENCE OF THE USE OF GENETICALLY ENGINEERED BIOLOGIC DRUGS IN THE TREATMENT OF RHEUMATOID ARTHRITIS AFTER TOFACITINIB
|
№7 / 2017
|
|
I.A. Starodubtseva
PHARMACOTHERAPY OF SECONDARY OSTEOARTHROSIS ON THE BACKGROUND OF COMORBID PATHOLOGY
|
№19 / 2015
|
|
V.V. Ryazhenov (1, 2), S.G. Gorokhov (2, 3), E.R. Volkova (2)
PHARMACOECONOMIC ANALYSIS OF DIFFERENT STRATEGIES OF MONOTHERAPY WITH GENETICALLY ENGINEERED BIOLOGICAL AGENTS IN RUSSIAN PATIENTS WITH RHEUMATOID ARTHRITIS
|
№7 / 2015
|
|
D.V. Bestaev
LUNG DIFFUSION CAPACITY IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INTERSTITIAL LUNG DISEASE
|
№4 / 2015
|
Русский
